Mayukh Sukhatme sold $34.1M of Roivant Sciences (ROIV)

Executed Jun 25, disclosed Jun 29, 4 days later.

Value, as filed

$34.1M

1,000,000 sh across 2 lots

Executed

Jun 25

the trade date, as filed

Disclosed

Jun 29

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Mayukh Sukhatme President & CIO profile →

Mayukh Sukhatme (President & CIO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $34.1M of ROIV (1,000,000 sh across 2 lots, as filed), executed Jun 25.

The name

ROIV

Roivant Sciences Ltd. ROIV · Healthcare · 75 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mayukh Sukhatme in ROIV

ROIVSALE Roivant Sciences Ltd. $12.4M
335,174 sh across 3 lots
Exec Aug 19
Filed Aug 21 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $24.2M
664,826 sh across 4 lots
Exec Aug 14
Filed Aug 18 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $9.0M
339,441 sh × $26.47
Exec Feb 9
Filed Feb 11 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $28.9M
1,330,868 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $620K
26,831 sh × $23.09
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $10.6M
886,237 sh across 3 lots
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $5.0M
412,584 sh × $12.05
Exec Dec 18 2024
Filed Dec 20 2024 · 5:30 PM ET